Microarray patches for transdermal drug delivery: a critical narrative review of technological innovations, CMC challenges, clinical translation, and global health implementation
Journal of Pharmacy & Pharmaceutical Sciences · 09.11.2026 · 29
DOI: 10.3389/jpps.2026.17200 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacy & Pharmaceutical Sciences, online erschienen am 09.11.2026. Verfasst von Priyabrata Pattnaik und 9 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 116 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Microarray patches (MAPs), alternatively known as microneedle patches, is a paradigm shift in the administration of pharmaceutical agents and vaccines. By utilising micron-scale projections to breach the stratum corneum, MAPs bridge the gap between the convenience of transdermal patches and the efficacy of hypodermic injections. This critical narrative review synthesises advances in MAP technology for transdermal drug delivery, focusing on technological innovations, chemistry, manufacturing, and control (CMC) challenges, clinical translation, regulatory considerations, and global health implementation. Special emphasis is placed on CMC challenges, including sterilisation and stability profiling, as well as the landscape of Clinical Trials, highlighting recent frameworks for pivotal Phase III studies in measles and rubella. We conclude by evaluating the programmatic suitability of MAPs for low- and middle-income countries (LMICs), addressing critical barriers such as cold-chain logistics and trypanophobia. A coordinated evolution from product-by-product model to platform-industrialisation model involving vaccine, polymer and device producing companies, regulators, global-health agencies including World health organization (WHO), and technology enablers is necessary. The Measles-Rubella programme provides an important template. MAPs’ value is not about replacing a syringe but enabling equitable distribution of vaccination; a strategy to make vaccination less dependent on infrastructure. As scientific innovations, upscaling, unified regulatory frameworks and equitable access advance, MAPs will achieve global relevance.
Zitieren
APA
Pattnaik, P., Tuglo, L. S., Alissa, M., Mishra, S., Alghamdi, A., Alshehri, M. A., Juraybi, T. N., Alanazi, H. G., Alnafesah, G. M., & Mohapatra, R. K. (2026). Microarray patches for transdermal drug delivery: a critical narrative review of technological innovations, CMC challenges, clinical translation, and global health implementation. Journal of Pharmacy & Pharmaceutical Sciences, 29. https://doi.org/10.3389/jpps.2026.17200
Vancouver
Pattnaik P, Tuglo LS, Alissa M, Mishra S, Alghamdi A, Alshehri MA, et al. Microarray patches for transdermal drug delivery: a critical narrative review of technological innovations, CMC challenges, clinical translation, and global health implementation. Journal of Pharmacy & Pharmaceutical Sciences. 2026;29. doi:10.3389/jpps.2026.17200
BibTeX
@article{Pattnaik2026,
author = {Pattnaik, Priyabrata and Tuglo, Lawrence Sena and Alissa, Mohammed and Mishra, Snehasish and Alghamdi, Abdullah and Alshehri, Mohammed A. and Juraybi, Tawfiq N. and Alanazi, Helal G. and Alnafesah, Ghada M. and Mohapatra, Ranjan K.},
title = {Microarray patches for transdermal drug delivery: a critical narrative review of technological innovations, CMC challenges, clinical translation, and global health implementation},
journal = {Journal of Pharmacy & Pharmaceutical Sciences},
year = {2026},
volume = {29},
doi = {10.3389/jpps.2026.17200}
}
EUVIMED